全球細胞冷凍保存市場

預計到 2030 年全球細胞冷凍保存市場規模將達 314 億美元

全球細胞冷凍保存市場規模預計在2024年為108億美元，預計到2030年將達到314億美元，2024年至2030年的複合年成長率為19.4%。作為細胞冷凍保存報告中分析的細分市場之一，耗材市場預計將以22.1%的複合年成長率成長，並在分析期結束時達到191億美元。細胞冷凍培養基市場在分析期間的複合年成長率預計為17.4%。

美國市場規模估計為 29 億美元，中國市場預期複合年成長率為 26.6%

美國細胞冷凍保存市場規模預計在2024年達到29億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到75億美元，在2024-2030年的分析期間內，複合年成長率為26.6%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為15.2%和17.5%。在歐洲，預計德國市場的複合年成長率約為16.3%。

全球細胞冷凍保存市場－主要趨勢與促進因素摘要

為什麼細胞冷凍保存的需求不斷增加？

隨著再生醫學、生物製藥研究和細胞治療方法的快速發展，細胞冷凍保存的需求日益成長。冷凍保存是保存生物材料（例如幹細胞、免疫細胞、生殖細胞和基因改造細胞）以供長期用於研究和臨床應用的關鍵過程。隨著個人化醫療的日益普及和幹細胞治療的不斷進步，可靠的冷凍保存技術對於確保細胞活力和功能至關重要。

此外，以再生療法、免疫療法和基因編輯技術為重點的臨床試驗的增加，進一步推動了對高品質冷凍保存解決方案的需求。醫院、研究機構和生物技術公司依靠冷凍保存來保存和運輸活細胞，以用於未來的醫療應用。隨著腫瘤學、神經病學和生殖醫學領域對細胞療法的需求不斷成長，細胞冷凍保存市場預計將持續擴張。

科技進步如何改善細胞冷凍保存？

冷凍保護劑配方、自動冷凍系統和低溫儲存解決方案的創新提高了細胞冷凍保存的效率和可靠性。其中最重要的進步之一是玻璃化冷凍技術的開發，該技術可防止冰晶形成並提高冷凍保存細胞的活力。與傳統的慢速冷凍方法不同，玻璃化冷凍技術可以實現超快速冷凍，從而保持細胞完整性並降低冷凍損傷的風險。

另一項重大突破是人工智慧監控系統和自動化液態液態氮儲存設施的出現。這些技術可確保最佳溫度控制，最大限度地減少樣本劣化，並實現對儲存細胞的即時追蹤。此外，冷凍保護劑的進步正在提高解凍後的細胞恢復率，同時降低毒性風險。在生物樣本庫中，區塊鏈在資料安全和可追溯性方面的整合也越來越受歡迎，提高了冷凍保存過程的透明度和合規性。冷凍通訊協定和儲存基礎設施的不斷改進，使細胞冷凍保存更有效率、可擴展，並可在多個醫療和研究領域廣泛應用。

哪些市場趨勢推動了細胞冷凍保存產業的發展？

對幹細胞庫和再生醫學日益成長的需求是影響細胞冷凍保存市場的最具影響力的趨勢之一。針對脊髓損傷、自體免疫疾病和心臟病等疾病的幹細胞療法需要長期儲存活細胞，這推動了對冷凍保存技術的投資。此外，生育力保存已成為一個主要的成長領域，越來越多的人選擇冷凍卵子、精子和胚胎以備將來生育之用。

影響市場成長的另一個關鍵趨勢是生物樣本庫計畫的擴張。各國政府和研究機構正在投資建造大型生物樣本庫，以支持基因組研究、藥物研發和個人化醫療。分散式冷凍保存服務的興起也推動了這一趨勢，該服務使得遠端採集和儲存生物樣本成為可能。此外，生物樣本庫和細胞療法生產領域的監管進步正在塑造產業格局，確保遵守良好生產規範 (GMP) 和倫理準則。隨著各行各業對細胞保存需求的成長，預計未來幾年市場將大幅擴張。

影響細胞冷凍保存市場未來發展的關鍵成長動力有哪些？

細胞冷凍保存市場的成長受到多種因素的推動，包括慢性病盛行率的上升、細胞治療方法的進步以及在生殖醫學領域的應用不斷拓展。主要成長要素之一是細胞免疫療法臨床試驗數量的增加，例如用於治療癌症的CAR-T細胞療法。這些療法需要穩定且可存活的細胞保存，因此冷凍保存成為先進治療通訊協定的重要組成部分。

影響市場的另一個關鍵促進因素是人們對生育治療服務的認知度和接受度的不斷提高。隨著晚育現像日益普遍，對冷凍保存生殖細胞的需求也隨之飆升，這促使世界各地的生育診所和生物樣本庫不斷擴張。此外，政府對幹細胞研究和再生醫學計畫的支持也推動了冷凍保存基礎設施的投資。隨著新的治療應用不斷湧現，對可靠、高品質的細胞冷凍保存解決方案的需求持續高漲，從而刺激了市場的持續成長。

部分

產品（儲存耗材、培養基、儲存設備）、用途（幹細胞、卵子、精子細胞、肝細胞、其他用途）、最終用途（IVF診所、生物製藥/製藥公司、生物庫、研究機構等）

受訪公司範例

• Avantor Inc.
• Biocision, LLC
• BioLife Solutions Inc.
• Cardinal Health, Inc.
• Cesca Therapeutics Inc.
• Chart Industries, Inc.
• Corning Incorporated
• Creative Biolabs
• CryoLife, Inc.
• Custom Biogenic Systems
• Danaher Corporation
• GE Healthcare
• Helmer Scientific
• HiMedia Laboratories
• Lonza Group Ltd.
• Merck KGaA
• Organ Recovery Systems Inc.
• PromoCell GmbH
• Sartorius AG
• Sigma-Aldrich Co. LLC

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 比賽

Global Cell Cryopreservation Market to Reach US$31.4 Billion by 2030

The global market for Cell Cryopreservation estimated at US$10.8 Billion in the year 2024, is expected to reach US$31.4 Billion by 2030, growing at a CAGR of 19.4% over the analysis period 2024-2030. Cell Cryopreservation Consumables, one of the segments analyzed in the report, is expected to record a 22.1% CAGR and reach US$19.1 Billion by the end of the analysis period. Growth in the Cell Freezing Media segment is estimated at 17.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.9 Billion While China is Forecast to Grow at 26.6% CAGR

The Cell Cryopreservation market in the U.S. is estimated at US$2.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.5 Billion by the year 2030 trailing a CAGR of 26.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.2% and 17.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.3% CAGR.

Global Cell Cryopreservation Market - Key Trends & Drivers Summarized

Why Is the Demand for Cell Cryopreservation Increasing?

The demand for cell cryopreservation is increasing due to the rapid growth of regenerative medicine, biopharmaceutical research, and cell-based therapies. Cryopreservation is a critical process in storing biological materials such as stem cells, immune cells, reproductive cells, and genetically modified cells for long-term use in research and clinical applications. With the rising adoption of personalized medicine and advancements in stem cell therapy, the need for reliable cryopreservation techniques has become essential for ensuring cell viability and functionality.

Additionally, the increasing number of clinical trials focused on regenerative treatments, immunotherapies, and gene-editing technologies has further driven the need for high-quality cryopreservation solutions. Hospitals, research institutions, and biotechnology companies rely on cryopreservation to store and transport viable cells for use in future medical applications. As demand grows for cell-based treatments in oncology, neurology, and reproductive health, the cell cryopreservation market is poised for continued expansion.

How Are Technological Advancements Improving Cell Cryopreservation?

Innovations in cryoprotectant formulations, automated freezing systems, and cryogenic storage solutions are enhancing the efficiency and reliability of cell cryopreservation. One of the most significant advancements is the development of vitrification techniques, which prevent ice crystal formation and improve the survival rates of cryopreserved cells. Unlike traditional slow-freezing methods, vitrification allows for ultra-rapid freezing, preserving cellular integrity and reducing the risk of cryo-injury.

Another major breakthrough is the use of AI-driven monitoring systems and automated liquid nitrogen storage facilities. These technologies ensure optimal temperature control, minimize sample degradation, and provide real-time tracking of stored cells. Additionally, advancements in cryoprotective agents are reducing toxicity risks while improving post-thaw cell recovery. The integration of blockchain for data security and traceability in biobanking is also gaining traction, enhancing transparency and compliance in cryopreservation processes. With continuous improvements in freezing protocols and storage infrastructure, cell cryopreservation is becoming more efficient, scalable, and accessible across multiple medical and research fields.

Which Market Trends Are Driving Growth in the Cell Cryopreservation Industry?

The increasing demand for stem cell banking and regenerative medicine is one of the most influential trends shaping the cell cryopreservation market. Stem cell therapies for conditions such as spinal cord injuries, autoimmune disorders, and heart disease require long-term storage of viable cells, driving investments in cryopreservation technologies. Additionally, fertility preservation has emerged as a major growth area, with more individuals opting to freeze eggs, sperm, and embryos for future reproductive use.

Another key trend influencing market growth is the expansion of biobanking initiatives. Governments and research institutions are investing in large-scale biorepositories to support genomic research, drug discovery, and personalized medicine. The rise of decentralized cryopreservation services, which enable remote collection and storage of biological samples, is also gaining traction. Additionally, regulatory advancements in biobanking and cell therapy manufacturing are shaping the industry, ensuring compliance with Good Manufacturing Practices and ethical guidelines. As the need for cell preservation grows across various sectors, the market is expected to experience significant expansion in the coming years.

What Are the Key Growth Drivers Shaping the Future of the Cell Cryopreservation Market?

The growth in the cell cryopreservation market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in cell-based therapies, and expanding applications in reproductive health. One of the primary growth drivers is the rising number of clinical trials for cellular immunotherapies, such as CAR-T cell therapy for cancer treatment. These therapies require stable and viable cell storage, making cryopreservation an essential component of advanced treatment protocols.

Another crucial driver shaping the market is the increasing awareness and adoption of fertility preservation services. With delayed parenthood becoming more common, demand for cryopreserved reproductive cells has surged, leading to the expansion of fertility clinics and biobanks worldwide. Additionally, government support for stem cell research and regenerative medicine initiatives is fueling investments in cryopreservation infrastructure. As new therapeutic applications continue to emerge, the need for reliable, high-quality cell cryopreservation solutions will remain strong, positioning the market for sustained growth in the years ahead.

SCOPE OF STUDY:

The report analyzes the Cell Cryopreservation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Cell Cryopreservation Consumables, Cell Freezing Media, Cell Cryopreservation Equipment); Application (Stem Cells Application, Oocytes and Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application, Other Applications); End-Use (IVF Clinics End-Use, Biopharmaceutical and Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Avantor Inc.
• Biocision, LLC
• BioLife Solutions Inc.
• Cardinal Health, Inc.
• Cesca Therapeutics Inc.
• Chart Industries, Inc.
• Corning Incorporated
• Creative Biolabs
• CryoLife, Inc.
• Custom Biogenic Systems
• Danaher Corporation
• GE Healthcare
• Helmer Scientific
• HiMedia Laboratories
• Lonza Group Ltd.
• Merck KGaA
• Organ Recovery Systems Inc.
• PromoCell GmbH
• Sartorius AG
• Sigma-Aldrich Co. LLC

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Cell Cryopreservation - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Adoption of Cell-Based Therapies Throws the Spotlight on Cell Cryopreservation as a Foundational Bioprocess
  • Growing Demand for Long-Term Cell Storage Solutions Propels Market for Cryopreservation Media and Technologies
  • Expansion of Stem Cell Research and Regenerative Medicine Drives Need for Advanced Cryopreservation Systems
  • Boom in Cell and Gene Therapy Development Strengthens the Business Case for Reliable Cryopreservation Infrastructure
  • Increasing Use of Cryopreserved Cells in Clinical Trials and Manufacturing Pipelines Expands the Addressable Market
  • Technological Advancements in Cryoprotectants and Controlled-Rate Freezing Enhance Cell Viability and Recovery Rates
  • Growth in Biobanking Initiatives and Personalized Medicine Programs Fuels Large-Scale Cell Storage Needs
  • Emerging Demand from Fertility Preservation, Cord Blood Banking, and Reproductive Health Boosts Market Diversification
  • Automation and Digital Integration in Cryostorage Facilities Improve Operational Efficiency and Sample Traceability
  • Cold Chain Expansion and Logistics Infrastructure Development Support Scalable Cryopreservation Solutions
  • Increasing Application in Immunotherapy and CAR-T Cell Therapy Drives Demand for High-Fidelity Cryopreservation Systems
  • R&D in Alternative Cryoprotectant Agents and Vitrification Techniques Opens New Avenues for Innovation
  • Globalization of Biomanufacturing and Clinical Trials Creates Demand for Multi-Site Cryopreservation Capabilities
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Cell Cryopreservation Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Cell Cryopreservation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Cell Cryopreservation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Cell Cryopreservation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Cell Cryopreservation Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Cell Cryopreservation Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Cell Cryopreservation Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Cell Freezing Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Cell Freezing Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Cell Freezing Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Cell Cryopreservation Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Cell Cryopreservation Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Cell Cryopreservation Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Biopharmaceutical & Pharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Biopharmaceutical & Pharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Biopharmaceutical & Pharmaceutical Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Biobanks End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Biobanks End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Biobanks End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for IVF Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for IVF Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for IVF Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Stem Cells Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Stem Cells Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Stem Cells Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Oocytes & Embryotic Cells Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Oocytes & Embryotic Cells Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Oocytes & Embryotic Cells Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Sperm Cells Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Sperm Cells Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Sperm Cells Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Hepatocytes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Hepatocytes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Hepatocytes Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Cell Cryopreservation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Cell Cryopreservation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Cell Cryopreservation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 92: France Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 119: UK Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Cell Cryopreservation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Cell Cryopreservation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Cell Cryopreservation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 176: India Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Cell Cryopreservation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Cell Cryopreservation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Cell Cryopreservation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Cell Cryopreservation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Cell Cryopreservation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Cell Cryopreservation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION